Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
Migraine, Vestibular Migraine, Vestibular Schwannoma
About this trial
This is an interventional basic science trial for Migraine focused on measuring sensory integration, cochlear implant, vestibular implant, balance, dizziness, vestibular disorders
Eligibility Criteria
Inclusion Criteria:
Normal subjects
- normal vestibular-oculomotor exams
- normal low-frequency standard rotational testing
- normal hearing
Migraine
- meets International Headache Society (IHS) criteria for migraine with or without aura
- tested more than 2 weeks after most recent migraine headache
Vestibular Migraine
- meets Barany Society criteria for vestibular migraine, which includes:
- episodic vestibular symptoms that occur with headaches that meet the IHS criteria for migraine
- tested more than 2 weeks after most recent migraine headache or vestibular episode
Vestibular Schwannoma
- existence of unilateral vestibular schwannoma (pre & post surgical resection)
- must have sub-occipital surgical approach with complete sectioning of the vestibular nerve
- rotational testing to assess pre-surgical vestibular function
- audiogram
- brain MRI consistent with vestibular schwannoma
- audiography in each ear
Vestibular (VI) and Cochlear (CI) Implant subjects
- scheduled for CI surgery because of deafness
- minimum 5 year history of documented absence of auditory and vestibular function, based on review of their audiograms and vestibular tests
- specific vestibular criteria: peak ice water caloric response of less than 3deg/s for each ear; yaw VOR time constant <3s and gain <0.25; and reduced head impulse gain (<0.25) for all canal planes
- specific audiographic criteria: 80dB or greater sensorineural hearing loss in both ears
Exclusion Criteria:
Normal subjects
- history of otologic or neurologic disease
- on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic)
Migraine
- history of vestibular symptoms (other than motion sickness)
- evidence of other neurologic or otologic dysfunction
- on migraine prophylactic medications
- on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic)
Vestibular Migraine (VM)
- other neurologic or otologic dysfunction as defined above except for central eye movement findings that are consistent with VM and therefore not exclusionary.
- on migraine prophylactic medication
- on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic)
Vestibular Schwannoma
- other otologic disease (other than presbycusis) or any neurologic disease (other than migraine)
- NF2
- on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic)
Sites / Locations
- Massachusetts Eye and Ear Infirmary
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Normal Controls
Central Vestibular Dysfunction
Peripheral Vestibular Dysfunction
Implant Subjects
normal control subjects - no history of neurologic or inner ear disease The investigators will characterize vestibular spatial and temporal precision by calculating perceptual thresholds and reaction times for vestibular (yaw rotation, ytranslation) stimuli in normal subjects over a wide age range. Vestibular-visual temporal binding is then performed on each subject and the relationship between the principal parameters (vestibular perceptual thresholds [inversely related to spatial precision], vestibular reaction time variability [inverse of temporal precision], and the PSS and TBW from the temporal binding paradigm) will be examined. The investigators will collect qualitative assessments of dizziness/disbalance (DHI: dizziness handicap index) and quantitative measurements of balance and vestibular function (FGA: functional gait analysis, postural sway, and standard rotational testing - VOR gain, time constant, asymmetry).
Migraine and Vestibular Migraine patients The investigators intend to evaluate vestibular (yaw rotation or y-translation) - visual temporal binding in people with a wide range of motion sickness sensitivities (as quantified with standard questionnaires), including normal subjects, people with migraine and with vestibular migraine. The investigators will use our standard adaption method to narrow the TBW in these subjects, and will also employ PSS adaptation if a consistent pattern emerges that relates MS sensitivity to the PSS. The investigators will induce motion sickness using a pseudo-Coriolis task (so susceptibility can be quantified pre and post training).
Vestibular Schwannoma patients The basic approach is to characterize the precision of their vestibular information (perceptual thresholds for spatial precision, reaction times for temporal precision), and their temporal binding characteristics for vestibular (yaw rotation or y-translation)-visual inputs, in three states: pre-op, sub-acute post-op (2-6 weeks), and chronic post-op (6 months+). At each state the investigators will also assess the quality of their vestibular-mediated behaviors through questionnaires (e.g. DHI), postural sway, functional gait analysis, and standard rotational testing (VOR gain, time constant, and asymmetry).
Cochlear Implant (CI)/Vestibular Implant (VI) patients A causative role for vestibular precision in temporal binding will be investigated in the VI patients, since the noise characteristics of the vestibular channel will be varied and to determine how this affects thresholds and temporal binding. As part of a second aim, the investigators will use VI and CI prosthetic signals in patients who have never received them together to see how the brain process sensory cues to which it is essentially naïve. Finally, after the acute experiments the investigators will provide 8 hours of 'physiologic' VI and CI stimulation by turning both implants on, sound modulates activity in the CI as usual, and angular head motion modulates activity in the VI while the subject actively explores the hospital environment.